Caricamento...
In vivo versus ex vivo CRISPR therapies for retinal dystrophy
Two therapeutic paths have been proposed to treat inherited retinal dystrophy using clustered regularly interspaced short palindromic repeats (CRISPR). One strategy is to genetically correct patient cells ex vivo for autologous transplant, whereas the second is to modify cells in vivo by delivering...
Salvato in:
| Pubblicato in: | Expert Rev Ophthalmol |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5289756/ https://ncbi.nlm.nih.gov/pubmed/28163772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17469899.2016.1251316 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|